David Weill - 10 Nov 2022 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role
Director
Signature
By: /s/ Stephen Gordon, Attorney-in-Fact
Issuer symbol
TMDX
Transactions as of
10 Nov 2022
Transactions value $
-$865,800
Form type
4
Filing time
14 Nov 2022, 18:17:55 UTC
Previous filing
06 Jun 2022
Next filing
28 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMDX Common Stock Options Exercise $346K +21.6K +160.33% $16.00 35.1K 10 Nov 2022 Direct
transaction TMDX Common Stock Sale -$1.21M -21.6K -61.59% $56.00 13.5K 10 Nov 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMDX Stock Option (Right to Buy) Options Exercise $0 -21.6K -100% $0.00* 0 10 Nov 2022 Common Stock 21.6K $16.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is fully vested.